
Cohance Lifesciences Investor Relations Material
Latest events

Q4 24/25
Cohance Lifesciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Cohance Lifesciences Limited
Access all reports
Suven Pharmaceuticals Limited is a pharmaceutical company engaged in the development, manufacturing, and supply of active pharmaceutical ingredients (APIs) and intermediates. The company primarily focuses on contract development and manufacturing services (CDMO) for global pharmaceutical companies, supporting drug discovery and commercial production. Its operations include process research, custom synthesis, and scale-up of complex molecules for use in various therapeutic areas. Suven Pharmaceuticals Limited serves clients across regulated and emerging markets. The company is headquartered in Hyderabad, India, and its shares are listed on the NSE.
Key slides for Cohance Lifesciences Limited


Q4 24/25
Cohance Lifesciences Limited


Q4 24/25
Cohance Lifesciences Limited
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
COHANCE
Country
🇮🇳 India